Sign in

You're signed outSign in or to get full access.

Manuel C. Menendez III

Director at Healthcare AI Acquisition
Board

About Manuel C. Menendez III

Independent director of Healthcare AI Acquisition Corp. (HAIA) since December 28, 2023; age 57 as disclosed at appointment. Nearly 40 years in international business across China, APAC, U.S., Europe, and Latin America; Founder/CEO/Director of MCM Group Holdings Ltd. since July 2015; previously CEO of Great Eastern Development, leading the first U.S.–China equity JV for a Fortune 100 company in 1980; pro bono advisor to UN WHO and UNEP. HAIA’s board classifies him as an independent director under Nasdaq/SEC standards.

Past Roles

OrganizationRoleTenureCommittees/Impact
MCM Group Holdings Ltd.Founder, CEO, DirectorSince Jul 2015International business development; cross-border investments focus
Great Eastern Development (GED)Chief Executive OfficerHistorical; led 1980 JVLed first U.S.–China equity JV for a Fortune 100 company

External Roles

OrganizationRoleTenureCommittees/Impact
World Health Organization (UN)Pro bono advisorNot disclosedHumanitarian/sustainable practices advisory
United Nations Environment Programme (UNEP)Pro bono advisorNot disclosedHumanitarian/sustainable practices advisory

Board Governance

  • Independence: The board has deemed Menendez independent; HAIA’s audit, compensation, and corporate governance/nomination functions are handled by independent directors.
  • Committee assignments and roles:
    • Audit Committee: Member (Chair: Nat Y. Chan; Chan designated audit committee financial expert).
    • Compensation Committee: Member and Chair.
    • Director nominations: As of the latest 10-K, HAIA has no standing nominating committee; a majority of independent directors handle nominations.
  • Classified board: Directors are divided into three classes with staggered three-year terms per Articles.
  • Policies and controls: Code of Ethics in place; Clawback Policy adopted under Exchange Act Section 10D.
  • Executive sessions: Independent directors have regularly scheduled meetings where only independent directors are present.
  • Structural context: Initial shareholders (sponsor and initial investors) control ~95% of voting power as of Sept. 17, 2025, indicating potential entrenchment risk not specific to Menendez.

Fixed Compensation

ComponentAmount/TermsNotes
Annual retainer (cash)$0“None of our executive officers or directors have received any cash compensation for services rendered to us.”
Committee fees$0No committee cash fees disclosed.
Meeting fees$0Not paid; only expense reimbursements.
Admin/office support$10,000/month reimbursed to former sponsor (ceased post-handover)Accrued $177,095 before sponsor handover; former sponsor waived; new sponsor will not charge admin fee.

Performance Compensation

Metric/InstrumentGrant/TermsNotes
Equity awards (RSUs/PSUs)None disclosedNo director equity awards disclosed prior to business combination.
OptionsNone disclosedNo option grants disclosed.
Bonus/Performance cashNoneSPAC structure—no cash comp to directors/officers prior to business combination.
Clawback provisionsBoard-adopted Clawback PolicyDesigned to comply with Exchange Act Section 10D.

Other Directorships & Interlocks

  • Current public company boards: None disclosed for Menendez.
  • Private/company roles: CEO/Director, MCM Group Holdings Ltd.
  • Interlocks: HAIA notes no compensation committee interlocks with Menendez in the past year.

Expertise & Qualifications

  • International business and cross-border investment expertise (China/APAC/US/EU/LatAm).
  • Not designated as audit committee financial expert (that role is assigned to Nat Y. Chan).

Equity Ownership

HolderAs of 12/28/2023As of 9/17/2025
Manuel C. Menendez III0 shares beneficially owned (Form 3)“Less than 1%” beneficial ownership (exact shares not disclosed in table)
Pledging/HedgingNot disclosedNot disclosed

Governance Assessment

  • Strengths:
    • Independent director serving on Audit and as Compensation Chair; independent oversight of executive pay policies (when applicable post-business combination) and related-party reviews.
    • International dealmaking experience aligns with HAIA’s cross-border transaction profile.
    • Clawback Policy and Code of Ethics in place.
  • Watch items / potential red flags:
    • Ownership alignment appears limited: Form 3 reported no beneficial ownership at appointment; later beneficial ownership disclosed only as “<1%,” with no detail—limited “skin in the game.”
    • Structural control by initial shareholders (~95% voting power as of Sept. 17, 2025) reduces minority investor influence; not specific to Menendez but a governance context risk.
    • No standing nominating committee as of latest 10-K; nominations handled by independent directors, which can be effective but concentrates process.
    • Attendance metrics not disclosed; no data on engagement frequency by director.

Related-party exposure: HAIA discloses audit committee review of related-party transactions and lists Menendez’s outside affiliation (MCM Group Holdings); no related-party transactions involving Menendez are disclosed.

Compensation outlook: As a SPAC, HAIA pays no director cash or equity compensation pre-business combination; post-close arrangements, if any, will be disclosed with the transaction.